BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Ischemia
,
Hippocampus
,
Anticancer prodrugs
,
Quercetin
,
rs4950928
,
VEGFA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
receptor fibroblast growth factor
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
L1000 CMAP - Non-small cell lung cancer HCC515 cells treated with ligand perturbagens
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
New Insights in the Interaction of FGF/FGFR and Steroid Receptor Signaling in Breast Cancer.
Heparin, klotho, and FGF23: the 3-beat waltz of the discordant heart.
Nano-Hydroxyapatite Stimulation of Gene Expression Requires Fgf Receptor, Phosphate Transporter, and…
Antibody-Mediated Targeting of the FGFR1c Isoform Increases Glucose Uptake in White and Brown Adipos…
Roseburia intestinalis relieves intrahepatic cholestasis of pregnancy through bile acid/FXR-FGF15 in…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Study to Identify Participants With Urothelial Cancer and Fibroblast Growth Factor Receptor Gene A…
A Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Participants With A…
A Study of Erdafitinib in Participants With Advanced Solid Tumors and Fibroblast Growth Factor Recep…
Phase I, Dose-escalation Trial of BAY1187982 in Subjects With Advanced Solid Tumors Known to Express…
Expanded Access Program (EAP) for Participants With Advanced Cancers and Fibroblast Growth Factor Re…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ